BVT 948

BVT 948

CAT N°: 16615
Price:

From 48.00 40.80

BVT 948 is a noncompetitive, cell-permeable inhibitor of protein tyrosine phosphatases (PTP; IC50s = 0.09-1.7 µM).{27664} It facilitates the oxidation of the catalytic cysteine residue by hydrogen peroxide.{27664} Similarly, it inhibits redox-sensitive cytochrome P450 (CYP) isoforms, including CYP2C19 and CYP2D6, with IC50 values less than 10 µM.{27664} BVT 948 also inhibits the protein methyltransferases SETD8, SETD2, G9a, SMYD2, CARM1, and PRMT3 with IC50 values from 0.7 to 3.2 µm.{26934} Presumably through its effects on PTPs, BVT 948 enhances insulin signaling in cells and insulin tolerance in ob/ob mice, suppresses the expression of matrix metalloproteinase-9 and invasion in breast cancer cells, and increases NMDA-induced substance P release by spinal cord slices.{27664,27665,27666}

Territorial Availability: Available through Bertin Technologies only in France

  • Synonyms
    • 4-hydroxy-3,3-dimethyl-2H-benz[g]indole-2,5(3H)-dione
  • Correlated keywords
    • matrix metalloproteinase-9 MMP-9 MMP9NMDA-induced N-Methyl-D-aspartic acid N-Methyl-D-
  • Product Overview:
    BVT 948 is a noncompetitive, cell-permeable inhibitor of protein tyrosine phosphatases (PTP; IC50s = 0.09-1.7 µM).{27664} It facilitates the oxidation of the catalytic cysteine residue by hydrogen peroxide.{27664} Similarly, it inhibits redox-sensitive cytochrome P450 (CYP) isoforms, including CYP2C19 and CYP2D6, with IC50 values less than 10 µM.{27664} BVT 948 also inhibits the protein methyltransferases SETD8, SETD2, G9a, SMYD2, CARM1, and PRMT3 with IC50 values from 0.7 to 3.2 µm.{26934} Presumably through its effects on PTPs, BVT 948 enhances insulin signaling in cells and insulin tolerance in ob/ob mice, suppresses the expression of matrix metalloproteinase-9 and invasion in breast cancer cells, and increases NMDA-induced substance P release by spinal cord slices.{27664,27665,27666}

We also advise you